bluuebunny/crossref_metadata_2025_split huggingface dataset:
Simvastatin prevents articular chondrocyte dedifferentiation induced by nitric oxide by inhibiting the expression of matrix metalloproteinases 1 and 13
Authors: Yu Seon-Mi , Kim Song Ja 
Published: January 2019

In this study, we investigated whether simvastatin (SVT), a statin commonly prescribed to decrease cholesterol levels, might have a therapeutic effect in OA. Primary rabbit chondrocytes were pre-treated with SVT (50 μM), then treated with sodium nitroprusside (SNP; 1 mM), a donor of nitric oxide (NO) known as a pro-inflammatory mediator, and analyzed for the expression levels of type II collagen, SOX-9, aggrecan, matrix metalloproteinases (MMPs) 1, and 13. SNP increased NO generation in a dose-dependent manner, causing a loss of type II collagen and aggrecan indicative of chondrocyte dedifferentiation, which was inhibited by SVT. SVT also reversed the increase in MMP-1 and -13 and inhibited NO production and NO synthase expression induced by SNP in articular chondrocytes. Given that MMP-1 and -13 knockdown by siRNA increased the level of type II collagen in SNP-treated cells, our results show that SVT prevented NO-induced chondrocyte damage and dedifferentiation through downregulation of MMP expression. This study showed that SVT could attenuate the degradation of articular cartilage components, which is characteristic for OA, through inhibition of MMPs in NO-treated chondrocytes, suggesting that SVT may be a novel candidate therapeutic agent for the prevention and/or treatment of OA.Impact statementDedifferentiation of chondrocytes is the main character of cartilage degradation. Therefore the understanding of chondrocytes dedifferentiation is essential for arthritis therapy. However, the molecular mechanism of cartilage destroy is mostly unknown. In this work we show that simvastatin (SVT) inhibits dedifferentiation by nitric oxide by blocking the expression of matrix metalloproteinases 1 and 13. These effects of SVT on dedifferentiation suggest that SVT may be used as a drug for the cure of arthritis.
Biomaterial substrate modifications that influence cell-material interactions to prime cellular responses to nonviral gene delivery
Authors: Mantz Amy , Pannier Angela K 
Published: January 2019

Gene delivery is the transfer of exogenous genetic material into somatic cells to modify their gene expression, with applications including tissue engineering, regenerative medicine, sensors and diagnostics, and gene therapy. Viral vectors are considered the most effective system to deliver nucleic acids, yet safety concerns and many other disadvantages have resulted in investigations into an alternative option, i.e. nonviral gene delivery. Chemical nonviral gene delivery is typically accomplished by electrostatically complexing cationic lipids or polymers with negatively charged nucleic acids. Unfortunately, nonviral gene delivery suffers from low efficiency due to barriers that impede transfection success, including intracellular processes such as internalization, endosomal escape, cytosolic trafficking, and nuclear entry. Efforts to improve nonviral gene delivery have focused on modifying nonviral vectors, yet a novel solution that may prove more effective than vector modifications is stimulating or “priming” cells before transfection to modulate and mitigate the cellular response to nonviral gene delivery. In applications where a cell-material interface exists, cell priming can come from cues from the substrate, through chemical modifications such as the addition of natural coatings, ligands, or functional side groups, and/or physical modifications such as topography or stiffness, to mimic extracellular matrix cues and modulate cellular behaviors that influence transfection efficiency. This review summarizes how biomaterial substrate modifications can prime the cellular response to nonviral gene delivery (e.g. integrin binding and focal adhesion formation, cytoskeletal remodeling, endocytic mechanisms, intracellular trafficking) to aid in improving gene delivery for future therapeutic applications. Impact statement This review summarizes how biomaterial substrate modifications (e.g. chemical modifications like natural coatings, ligands, or functional side groups, and/or physical modifications such as topography or stiffness) can prime the cellular response to nonviral gene delivery (e.g. affecting integrin binding and focal adhesion formation, cytoskeletal remodeling, endocytic mechanisms, and intracellular trafficking), to aid in improving gene delivery for applications where a cell-material interface might exist (e.g. tissue engineering scaffolds, medical implants and devices, sensors and diagnostics, wound dressings).
Development of a Questionnaire to Determine Incidence and Attitudes to “Voluntary Stopping of Eating and Drinking”
Authors: Stängle Sabrina , Schnepp Wilfried , Mezger Mirjam , Büche Daniel , Fringer André 
Published: January 2019

Background “Voluntary stopping of eating and drinking” (VSED) is an option to hasten death at the end of life. There are no data available about incidence of either the explicit VSED or implicit (V)SED nor information about experiences and attitudes of health professionals about VSED in Switzerland. Aims To develop, test, and translate a standardized questionnaire that measures the incidence of VSED, and physicians’ and nurses’ experiences about explicit VSED and implicit (V)SED. Methods The development of the questionnaire was based on a systematic search, which were updated in 2016. The questionnaire was tested by palliative care specialists using standard pretest and content validity index (CVI). Subsequently, a forward/backward translation was made. Results The questionnaire includes 38 items. Feedback of 15 participants in the standard pretest were positive in terms of intelligibility with an average time of 28 minutes. After adjustment, 27 experts validated the items in two rounds. The questionnaire achieves excellent item-CVI values between 0.91 and 1.00 and scale-CVI values of 0.97. The forward/backward translations were each carried out by two independent translators with subsequent building of a consensus through a consultant. Conclusion A mulitlingual questionnaire has been developed, which measures the incidence of explicit VSED and implicit (V)SED. This questionnaire is the basis for a Swiss-wide census of all physicians and nurses of outpatient and long-term care.
Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors
Authors: Wakamatsu Manabu , Terakura Seitaro , Ohashi Kazuteru , Fukuda Takahiro , Ozawa Yukiyasu , Kanamori Heiwa , Sawa Masashi , Uchida Naoyuki , Ota Shuichi , Matsushita Akiko , Kanda Yoshinobu , Nakamae Hirohisa , Ichinohe Tatsuo , Kato Koji , Murata Makoto , Atsuta Yoshiko , Teshima Takanori 
Published: January 2019

AbstractAntithymocyte globulin (ATG) is widely used to reduce acute graft-versus-host disease (aGVHD) and chronic GVHD (cGVHD). To clarify the different impacts of ATG for conditioning across different donor types, we retrospectively analyzed patients with acute leukemia (n = 6617) who underwent hematopoietic stem cell transplantation between 2008 and 2015 with ATG (n = 279) or without ATG (n = 6338). Because thymoglobulin is the only ATG drug approved for GVHD prophylaxis in Japan since September 2008, we included thymoglobulin alone in the present analysis. The survivors’ median follow-up time was 1081 days. Patients were categorized into 5 groups: cord blood (CB; n = 1915), matched related donor (n = 1772), 1-antigen mismatched related donor (1-MMRD; n = 225), matched unrelated donor (MUD; n = 1742), and 1-allele mismatched unrelated donor (1-MMUD; n = 963). In multivariate analysis, ATG decreased overall survival (hazard ratio [HR], 1.403; P = .054) and GVHD-free/relapse-free survival (GRFS) (HR, 1.458; P = .053) in association with increased nonrelapse mortality (NRM) (HR, 1.608; P = .03) with CB, whereas it improved GRFS (HR, 0.515; P &lt; .01) and decreased grades II to IV aGVHD (HR, 0.576; P &lt; .01), extensive cGVHD (HR, 0.460; P = .02), and NRM (HR, 0.545; P = .03) with 1-MMUD. ATG did not impact survival with 1-MMRD and MUD. The use of ATG in conditioning is beneficial due to the reduction in acute/chronic GVHD without increasing NRM or disease relapse only in 1-MMUD transplantation. On the other hand, ATG is not recommended for CB transplantation.
Performance prediction of data streams on high-performance architecture
Authors: Gautam Bhaskar , Basava Annappa 
Published: January 2019

Abstract
Worldwide sensor streams are expanding continuously with unbounded velocity in volume, and for this acceleration, there is an adaptation of large stream data processing system from the homogeneous to rack-scale architecture which makes serious concern in the domain of workload optimization, scheduling, and resource management algorithms. Our proposed framework is based on providing architecture independent performance prediction model to enable resource adaptive distributed stream data processing platform. It is comprised of seven pre-defined domain for dynamic data stream metrics including a self-driven model which tries to fit these metrics using ridge regularization regression algorithm. Another significant contribution lies in fully-automated performance prediction model inherited from the state-of-the-art distributed data management system for distributed stream processing systems using Gaussian processes regression that cluster metrics with the help of dimensionality reduction algorithm. We implemented its base on Apache Heron and evaluated with proposed Benchmark Suite comprising of five domain-specific topologies. To assess the proposed methodologies, we forcefully ingest tuple skewness among the benchmarking topologies to set up the ground truth for predictions and found that accuracy of predicting the performance of data streams increased up to 80.62% from 66.36% along with the reduction of error from 37.14 to 16.06%.
Colouring of Pacific barkcloths: identification of the brown, red and yellow colourants used in the decoration of historic Pacific barkcloths
Authors: Flowers T. H. , Smith M. J. , Brunton J. 
Published: January 2019

Abstract
Barkcloth textiles made in the Pacific islands and collected by western explorers in the eighteenth and nineteenth centuries form part of many museum collections worldwide. Here high-performance liquid chromatography (HPLC) and X-ray fluorescence (XRF) were used on cloths that were highly coloured or pigmented specifically focussing on identifying the red, yellow and brown colorants. The cloths studied came from collections held at the Hunterian, University of Glasgow, the Economic Botany Collection, Royal Botanic Gardens Kew and the Centre for Textile Conservation and Technical Art History, University of Glasgow. HPLC analysis was carried out following a sequential extraction procedure to minimise changes to the colorants during extraction. A portable XRF was used so no invasive sampling was required. A small number of plant derived colorants were found, Morinda citrifolia, noni (morindin or morindone), Rubia tinctorum (madder), tree tannins and Curcuma longa (turmeric) plus an inorganic colorant, iron oxide. For 40 samples a single colorant was found while in the remaining 12 samples combinations of up to three colorants were found. Madder was found in only 2 samples on the same cloth. The morindone coloured samples were all red whereas morindin samples were both red and yellow. Morindin was used predominantly in combination with other colouring agents. A combination of iron ochre and organic colorant was found in 4 samples. These findings show that despite the numerous potential colorant sources for red, brown and yellow shades listed in the many accounts of historic barkcloth making, only five types of plant colourant and one inorganic pigment were found. There are a number of potential reasons for these findings. Some colours may have faded and so no longer appear coloured. It is also possible that, as some of these cloths were prepared specifically as gifts for visitors or for ceremonial uses, the makers used materials that they knew would retain their integrity over time. Perhaps, like artisans worldwide, experience had taught them that some colorants, although initially bright and vivid, faded over time.
Unveiling Harriet Backer: ICP–OES study for the characterisation of the colour tubes from her original paint box
Authors: Caruso Francesco , Mantellato Sara , Streeton Noëlle L. W. , Frøysaker Tine 
Published: January 2019

Abstract
Micro-samples from 57 original paint tubes used between 1904 and 1909 by the Norwegian painter, Harriet Backer were studied with inductively coupled plasma–optical emission spectroscopy (ICP–OES). This accurate elemental characterisation of Backer’s original materials aims to fill several gaps in conservation science, painting conservation, and art technology. Firstly, it provides a novel and validated analytical method that can be applied to other painting materials. Secondly, ICP–OES offers scientific information about different oil colours from the late 19th to the early 20th century by Dr. Schoenfeld & Co., Düsseldorf, currently known as Lukas–Nerchau, whose archives were depleted during the Second World War. This work also lends new insights into the paintings of a renowned female Norwegian artist, whose painting materials have been little studied to date. ICP–OES results, coupled with a comprehensive, illustrated catalogue of paint tubes, will be instrumental for ongoing scientific investigations of this painter’s body of work.
The replicability of ICD-11 complex post-traumatic stress disorder symptom networks in adults
Authors: Knefel Matthias , Karatzias Thanos , Ben-Ezra Menachem , Cloitre Marylene , Lueger-Schuster Brigitte , Maercker Andreas 
Published: January 2019

BackgroundThe ICD-11 includes a new disorder, complex post-traumatic stress disorder (CPTSD). A network approach to CPTSD will enable investigation of the structure of the disorder at the symptom level, which may inform the development of treatments that target specific symptoms to accelerate clinical outcomes.AimsWe aimed to test whether similar networks of ICD-11 CPTSD replicate across culturally different samples and to investigate possible differences, using a network analysis.MethodWe investigated the network models of four nationally representative, community-based cross-sectional samples drawn from Germany, Israel, the UK, and the USA (totalN= 6417). CPTSD symptoms were assessed with the International Trauma Questionnaire in all samples. Only those participants who reported significant functional impairment by CPTSD symptoms were included (N= 1591 included in analysis; mean age 43.55 years, s.d. 15.10, range 14–99, 67.7% women). Regularised partial correlation networks were estimated for each sample and the resulting networks were compared.ResultsDespite differences in traumatic experiences, symptom severity and symptom profiles, the networks were very similar across the four countries. The symptoms within dimensions were strongly associated with each other in all networks, except for the two symptom indicators assessing aspects of affective dysregulation. The most central symptoms were ‘feelings of worthlessness’ and ‘exaggerated startle response’.ConclusionsThe structure of CPTSD symptoms appears very similar across countries. Addressing symptoms with the strongest associations in the network, such as negative self-worth and startle reactivity, will likely result in rapid treatment response.Declaration of interestA.M. and M.C. were members of the World Health Organization (WHO) ICD-11 Working Group on the Classification of Disorders Specifically Associated with Stress, reporting to the WHO International Advisory Group for the Revision of ICD-10 Mental and Behavioural Disorders. The views expressed in this article are those of the authors and do not represent the official policies or positions of the International Advisory Group or the WHO.
Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk
Authors: Arasu Vignesh A. , Miglioretti Diana L. , Sprague Brian L. , Alsheik Nila H. , Buist Diana S.M. , Henderson Louise M. , Herschorn Sally D. , Lee Janie M. , Onega Tracy , Rauscher Garth H. , Wernli Karen J. , Lehman Constance D. , Kerlikowske Karla 
Published: January 2019

PURPOSE To evaluate comparative associations of breast magnetic resonance imaging (MRI) background parenchymal enhancement (BPE) and mammographic breast density with subsequent breast cancer risk. PATIENTS AND METHODS We examined women undergoing breast MRI in the Breast Cancer Surveillance Consortium from 2005 to 2015 (with one exam in 2000) using qualitative BPE assessments of minimal, mild, moderate, or marked. Breast density was assessed on mammography performed within 5 years of MRI. Among women diagnosed with breast cancer, the first BPE assessment was included if it was more than 3 months before their first diagnosis. Breast cancer risk associated with BPE was estimated using Cox proportional hazards regression. RESULTS Among 4,247 women, 176 developed breast cancer (invasive, n = 129; ductal carcinoma in situ,n = 47) over a median follow-up time of 2.8 years. More women with cancer had mild, moderate, or marked BPE than women without cancer (80% v 66%, respectively). Compared with minimal BPE, increasing BPE levels were associated with significantly increased cancer risk (mild: hazard ratio [HR], 1.80; 95% CI, 1.12 to 2.87; moderate: HR, 2.42; 95% CI, 1.51 to 3.86; and marked: HR, 3.41; 95% CI, 2.05 to 5.66). Compared with women with minimal BPE and almost entirely fatty or scattered fibroglandular breast density, women with mild, moderate, or marked BPE demonstrated elevated cancer risk if they had almost entirely fatty or scattered fibroglandular breast density (HR, 2.30; 95% CI, 1.19 to 4.46) or heterogeneous or extremely dense breasts (HR, 2.61; 95% CI, 1.44 to 4.72), with no significant interaction ( P = .82). Combined mild, moderate, and marked BPE demonstrated significantly increased risk of invasive cancer (HR, 2.73; 95% CI, 1.66 to 4.49) but not ductal carcinoma in situ (HR, 1.48; 95% CI, 0.72 to 3.05). CONCLUSION BPE is associated with future invasive breast cancer risk independent of breast density. BPE should be considered for risk prediction models for women undergoing breast MRI.
3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release
Authors: Öblom Heidi , Zhang Jiaxiang , Pimparade Manjeet , Speer Isabell , Preis Maren , Repka Michael , Sandler Niklas 
Published: January 2019

Abstract
The aim of the present work was to produce 3D-printed oral dosage forms with a sufficient drug dose displaying various release profiles. Hot-melt extrusion was utilized to produce drug-loaded feedstock material that was subsequently 3D-printed into 6, 8, and 10 × 2.5 mm tablets with 15% and 90% infill levels. The prepared formulations contained 30% (w/w) isoniazid in combination with one or multiple pharmaceutical polymers possessing suitable properties for oral drug delivery. Thirteen formulations were successfully hot-melt extruded of which eight had properties suitable for fused deposition modeling 3D printing. Formulations containing HPC were found to be superior regarding printability in this study. Filaments with a breaking distance below 1.5 mm were observed to be too brittle to be fed into the printer. In addition, filaments with high moisture uptake at high relative humidity generally failed to be printable. Different release profiles for the 3D-printed tablets were obtained as a result of using different polymers in the printed formulations. For 8 mm tablets printed with 90% infill, 80% isoniazid release was observed between 40 and 852 min. Drug release characteristics could further be altered by changing the infill or the size of the printed tablets allowing personalization of the tablets. This study presents novel formulations containing isoniazid for prevention of latent tuberculosis and investigates 3D printing technology for personalized production of oral solid dosage forms enabling adjustable dose and drug release properties.
Successful Multimodal Treatment of an IGF2-Producing Solitary Fibrous Tumor With Acromegaloid Changes and Hypoglycemia
Authors: De Los Santos-Aguilar Ramón G , Chávez-Villa Mariana , Contreras Alan G , García-Herrera Juan S , Gamboa-Domínguez Armando , Vargas-Sánchez Joel , Almeda-Valdes Paloma , Reza-Albarrán Alfredo A , Iñiguez-Ariza Nicole M 
Published: January 2019

AbstractDoege–Potter syndrome with acromegaloid facial changes is extremely rare. Uncooked cornstarch along with glucocorticoids have been used as supportive care in patients with non–islet cell tumor hypoglycemia (NICTH). Preoperative embolization of hepatic solitary fibrous tumors (SFT) with NICTH has yielded unsatisfactory results. Herein we present the case of a 61-year-old man with a 3-month history of severe frequent hypoglycemic episodes and acromegaloid facial changes. During a spontaneous hypoglycemia (26 mg/dL), laboratory values showed a hypoinsulinemic pattern with low levels of GH, IGFPB3, and an IGF2/IGF1 ratio of 8.5:1. Cross-sectional imaging revealed a large (16 × 13 × 11 cm) hepatic tumor, and cytology was consistent with SFT. A preoperative right portal embolization was performed in an effort to induce normal remnant liver hypertrophy to allow for safe tumor resection. After the procedure, uncooked starch treatment followed by prednisone was started, achieving complete remission of hypoglycemic episodes in the preoperative setting. He subsequently underwent partial hepatectomy. The histologic diagnosis was compatible with a potentially malignant SFT. The patient had an excellent outcome with complete remission of hypoglycemia, improvement of facial acromegaloid changes, and no further evidence of disease. To our knowledge, this is the first case of a patient with Doege–Potter syndrome with acromegaloid facial changes induced by a potentially malignant liver SFT, treated successfully with a multimodal approach consisting of uncooked cornstarch, low-dose prednisone, preoperative embolization, and complete surgical resection. The use of cornstarch and low-dose glucocorticoids may be an adequate treatment in advance of undergoing surgery.
Does the Lending Rate Impact ETF's Prices?
Authors: De Genaro Alan , Avellaneda Marco 
Published: January 2019

In this paper we developed an econometric model to empirically test the hard-to-borrow model of Avellaneda and Lipkin (2009) where asset prices jump as result of ``buy-in" procedures. The model is estimated using an extent version of simulated maximum likelihood (SML) for a selected group of Leveraged ETF, mainly short LETFs, because these instruments have been sporadically hard-to-borrow and are liquids. In general we do not find enough statistical evidence supporting that hard-to-borrow effect impacts LETFs prices. On the other hand, we did find statistical evidence supporting the jump-diffusion model for some Leveraged ETFs.